About Bausch & Lomb
Bausch & Lomb is a company based in Bridgewater (United States) founded in 1853 by John Jacob Bausch and Henry Lomb was acquired by Bausch Health in May 2013.. The company has 13,500 employees as of December 31, 2024. Bausch & Lomb has completed 12 acquisitions, including AcuFocus, Doctor's Allergy Formula and ELIOS Vision. Bausch & Lomb operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Bridgewater, United States
- Employees 13500 as on 31 Dec, 2024
- Founders John Jacob Bausch, Henry Lomb
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bausch + Lomb Corporation
-
Annual Revenue
$4.79 B15.56as on Dec 31, 2024
-
Net Profit
$-317 M-21.92as on Dec 31, 2024
-
EBITDA
$642 M9.56as on Dec 31, 2024
-
Latest Funding Round
-
Investors
Bausch Health
& 2 more
-
Employee Count
13500
as on Dec 31, 2024
-
Investments & Acquisitions
AcuFocus
& 11 more
-
Acquired by
Bausch Health
(May 27, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bausch & Lomb
Bausch & Lomb is a publicly listed company on the NYSE with ticker symbol BLCO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Funding Insights of Bausch & Lomb
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(28 Jul 2015)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Post-IPO - Bausch & Lomb | Valuation |
investors |
|
| Jul, 2015 | Amount | Grant - Bausch & Lomb | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bausch & Lomb
Bausch & Lomb has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Bausch Health, IMRF and RGE. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bausch & Lomb
Bausch & Lomb has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include AcuFocus, Doctor's Allergy Formula and ELIOS Vision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Excimer laser technology is applied to develop glaucoma therapy devices.
|
2019 | ||||
|
Therapeutics for ophthalmological disorders, including glaucoma treatments, are developed.
|
2015 | ||||
|
Diagnostics for ocular allergies are developed using regional allergen panels.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bausch Lomb
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bausch & Lomb Comparisons
Competitors of Bausch & Lomb
Bausch & Lomb operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bausch & Lomb
Frequently Asked Questions about Bausch & Lomb
When was Bausch & Lomb founded?
Bausch & Lomb was founded in 1853 and raised its 1st funding round 162 years after it was founded.
Where is Bausch & Lomb located?
Bausch & Lomb is headquartered in Bridgewater, United States. It is registered at Bridgewater, New Jersey, United States.
How many employees does Bausch & Lomb have?
As of Dec 31, 2024, the latest employee count at Bausch & Lomb is 13,500.
What is the annual revenue of Bausch & Lomb?
Annual revenue of Bausch & Lomb is $4.79B as on Dec 31, 2024.
What does Bausch & Lomb do?
Bausch Lomb was founded in 1853 and is headquartered in Bridgewater, United States. Focus is placed on the ophthalmology sector, where pharmaceutical products, contact lenses, lens care items, eye care solutions, over-the-counter offerings, and surgical devices are developed and distributed. Operations encompass research, manufacturing, and global supply of these instruments and products to support eye health and vision correction needs.
Who are the top competitors of Bausch & Lomb?
Bausch & Lomb's top competitors include Merck, Roivant Sciences and AbbVie.
Is Bausch & Lomb publicly traded?
Yes, Bausch & Lomb is publicly traded on NYSE under the ticker symbol BLCO.
How many acquisitions has Bausch & Lomb made?
Bausch & Lomb has made 12 acquisitions, including AcuFocus, Doctor's Allergy Formula, and ELIOS Vision.
Who are Bausch & Lomb's investors?
Bausch & Lomb has 3 investors. Key investors include Bausch Health, IMRF, and RGE.
What is Bausch & Lomb's ticker symbol?
The ticker symbol of Bausch & Lomb is BLCO on NYSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.